Skip to main content

Table 2 Nanocarriers applied in molecular imaging methods to visualize the ischemic brain

From: Advances of nano drug delivery system for the theranostics of ischemic stroke

Molecular imaging methods

Shortcomings before enhancement

Improved methods for applying nanocarriers

Results

Refs.

Magnetic resonance imaging (MRI)

Low signal intensity and sensitivity

MNPs conjugated with antibodies

Become both a MRI contrast enhancement agent and a selective biological recognizer of target molecules

[64]

Lipid-encapsulated perflurocarbon NPs

Detect the microthrombin that form on the intimal surfaces of unstable atherosclerotic plaque sensitively and specifically

[67]

An integrin αvβ3-specific Fe3O4 nanoprobe modified with RGD tripeptide

Visualize the collaterals during acute IS

[68]

PEGylated ultrasma paramagnetic Gd2O3 NPs

Label and track cells in brain

[69]

Positron emission spectroscopy (PET)

Always used together with MRI and CT

NPs consisted of a SPIO core labelled with 64Cu and coated with PEGylated phospholipids

Show high initial blood retention with moderate liver uptake

[72]

18F-modified polyglucose NPs

Exhibit high affinity for macrophages

[73]

Computed tomography (CT)

Not sensitive within the differentiation of penumbral and infarct core region

Au NPs grown in the PEGylated dendrimer

Achieve a blood pool imaging better than a commercial iodine agent

[77]

PEGylated BaHoF5 nanoprobes

Much lower dosage required, main metabolism through liver and better imaging efficiency at different voltages

[78]

Exosome-labeled with glucose coated gold nanoparticles

Exhibit better accumulation of particles in the ischemic region

[81]

Ultrasonography

Difficult to penetrate the cranium

PDI NPs conjugated with cRGD

Monitor the obstructive degree of thrombus and the thrombolysis effect in time

[84]